Suscribirse

Universal Cholesterol Screening among Pediatric Primary Care Providers within California and Minnesota: A Qualitative Assessment of Barriers and Facilitators - 21/05/21

Doi : 10.1016/j.jpeds.2021.02.065 
Jenna Soukup, MS, CGC 1, Heather A. Zierhut, PhD, MS, CGC 1, , Hannah E. Ison, MS, CGC 2, 3,

UMN Genetic Counseling Program Class of 2020

1 Department of Genetics, Cell Biology, & Development, University of Minnesota – Twin Cities, Minneapolis, MN 
2 Stanford Center for Inherited Cardiovascular Disease, Stanford Health Care, Stanford, CA 
3 Division of Cardiology in the Department of Pediatrics, Stanford Medicine, Stanford, CA 

Reprint requests: Hannah E. Ison, MS, CGC, Stanford Center for Inherited Cardiovascular Disease, 300 Pasteur Dr, Stanford, CA 94305.Stanford Center for Inherited Cardiovascular Disease300 Pasteur DrStanfordCA94305

Abstract

Objective

To assess current pediatric cholesterol screening practices, and attitudes, among pediatric primary care providers (PCPs) via qualitative semistructured interviews designed to identify barriers and facilitators to universal cholesterol screening practices recommended by the National Heart Blood and Lung Institute and the American Academy of Pediatrics.

Study design

An online survey and subsequent 30-minute semistructured phone interview were completed with PCPs from regions in Northern California and Minnesota (survey n = 25, interview n = 12). Interviews were qualitatively analyzed using the consolidated framework for implementation research to categorize barriers, facilitators, and strategies to increase pediatric cholesterol screening among PCPs.

Results

PCPs from California (n = 8) and Minnesota (n = 4) consistently identified cost of cholesterol screening, particularly the cost of time due to competing visit priorities, as a barrier. A supportive learning environment, feelings of self-efficacy, access to resources, and well-established clinical networks with specialists (eg, cardiologists) were facilitators to screening. The perceived level of endorsement behind cholesterol screening within the clinic, perceived validity of national guidelines, and ability to adapt guidelines to existing clinical workflow were notable differentiators between high vs low self-reported screen rates.

Conclusions

Findings of this study suggest that efforts to increase universal pediatric cholesterol screening will likely require the development of strategies to increase provider education about the long-term benefits of cholesterol screening (knowledge and beliefs), and ensuring providers feel supported and empowered when assessing/acting on the results of this screening (self-efficacy, engaging leaders, networks, and communication).

El texto completo de este artículo está disponible en PDF.

Key words : pediatric, cholesterol screening guidelines, familial hypercholesterolemia, FH, CFIR, barriers, facilitators, implementation, prevention

Abbreviations : CFIR, FH, PCP


Esquema


 Funding provided by the University of Minnesota Genetic Counseling Program and Department of Genetics, Cell Biology, and Development as well as Stanford Medicine Division of Cardiology in the Department of Pediatrics. The authors declare no conflicts of interest.


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 233

P. 175 - juin 2021 Regresar al número
Artículo precedente Artículo precedente
  • Blood Pressure Response to Treadmill Cardiopulmonary Exercise Test in Children with Normal Cardiac Anatomy and Function
  • Takeshi Sasaki, Yuki Kawasaki, Daiji Takajo, Chenni Sriram, Robert D. Ross, Daisuke Kobayashi
| Artículo siguiente Artículo siguiente
  • 50 Years Ago in The Journal of Pediatrics : The Ever Elusive Attention Deficit Hyperactivity Disorder Blood Test
  • Jessica M. Jary, Terrill Bravender

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.